Smith & Nephew PLC
LSE:SN

Watchlist Manager
Smith & Nephew PLC Logo
Smith & Nephew PLC
LSE:SN
Watchlist
Price: 971.4 GBX 0.87%
Market Cap: 8.5B GBX
Have any thoughts about
Smith & Nephew PLC?
Write Note
Section:
 

Relative Value

The Relative Value of one SN stock under the Base Case scenario is 1 862.2 GBX. Compared to the current market price of 971.4 GBX, Smith & Nephew PLC is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SN Relative Value
Base Case
1 862.2 GBX
Undervaluation 48%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
88
vs Industry
47
Median 3Y
2.3
Median 5Y
2.7
Industry
2.4
Forward
0
More Details
35.8
P/E
P/E
Price to Earnings
35.8
vs History
50
vs Industry
9
Median 3Y
41.7
Median 5Y
36.4
Industry
22.9
Forward
0.3
More Details
14.9
P/OCF
P/OCF
Price to OCF
14.9
vs History
77
vs Industry
19
Median 3Y
18
Median 5Y
17.6
Industry
14.5
More Details
14.4
P/FCFE
P/FCFE
Price to FCFE
14.4
vs History
55
vs Industry
10
Median 3Y
34.3
Median 5Y
15.8
Industry
20.5
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
82
vs Industry
37
Median 3Y
2.3
Median 5Y
2.6
Industry
2.2
More Details
55.7
EV/S
EV/S
Enterprise Value to Sales
55.7
vs History
6
vs Industry
5
Median 3Y
46.6
Median 5Y
43.9
Industry
2.4
Forward
0.5
More Details
80.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
80.7
vs History
6
vs Industry
4
Median 3Y
65.7
Median 5Y
62.1
Industry
5
More Details
232
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
232
vs History
15
vs Industry
1
Median 3Y
185.7
Median 5Y
172.1
Industry
12.6
Forward
2.2
More Details
451.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
451.7
vs History
15
vs Industry
0
Median 3Y
334.4
Median 5Y
335.2
Industry
17.1
Forward
3.3
More Details
428.9
EV/OCF
EV/OCF
Enterprise Value to OCF
428.9
vs History
25
vs Industry
1
Median 3Y
401.3
Median 5Y
292.3
Industry
14.1
More Details
1 044.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
1 044.5
vs History
33
vs Industry
0
Median 3Y
1 052.9
Median 5Y
665.7
Industry
17.7
More Details
35.1
EV/IC
EV/IC
Enterprise Value to IC
35.1
vs History
6
vs Industry
2
Median 3Y
28.4
Median 5Y
27.8
Industry
1.9
More Details

Multiples Across Competitors

SN Competitors Multiples
Smith & Nephew PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Smith & Nephew PLC
LSE:SN
8.4B GBP 1.9 35.8 232 451.7
US
Abbott Laboratories
NYSE:ABT
204.7B USD 5 35.5 20.7 30.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.7B USD 23 80.6 68.7 85.3
US
Stryker Corp
NYSE:SYK
139.9B USD 6.4 39 25.3 30.7
US
Boston Scientific Corp
NYSE:BSX
124.8B USD 7.8 69.6 32 45.8
IE
Medtronic PLC
NYSE:MDT
114.5B USD 3.5 29.2 15.2 21.7
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD 3.4 47.9 15.4 27.3
DE
Siemens Healthineers AG
XETRA:SHL
53.6B EUR 2.4 28.8 16.6 24.2
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
338.5B CNY 9.2 26.7 23.5 23.5
US
Edwards Lifesciences Corp
NYSE:EW
40B USD 7.1 9.6 22.2 24.3
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.7B USD 2 23.7 14.7 18.1

See Also

Summary
SN intrinsic value, competitors valuation, and company profile.
DCF Valuation
SN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SN stock valuation using valuation multiples.
Wall Street Estimates
SN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 194,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.